Inhibitor Therapeutics, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 0.298632 million compared to USD 1.06 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.13 USD | +46.12% | +7.79% | +41.30% |
29/03 | Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board | CI |
1st Jan change | Capi. | |
---|---|---|
+41.30% | 15.3M | |
+7.12% | 113B | |
+10.91% | 106B | |
+0.84% | 22.27B | |
-12.33% | 22.22B | |
-5.66% | 19.43B | |
-37.85% | 17.87B | |
-5.59% | 17.24B | |
+6.85% | 14.29B | |
+35.08% | 12.52B |
- Stock Market
- Equities
- INTI Stock
- News Inhibitor Therapeutics, Inc.
- Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021